Summary
Machine-generated summaryAOK Bayern intends to conclude non-exclusive rebate agreements with all interested pharmaceutical companies for the active substance Lopinavir and Ritonavir, ATC J05AR10, under Section 130a(8) SGB V. This is an open-house model offering identical, non-negotiable rebate terms rather than a competitive award procedure. Contracts may start from 1 November 2026, end on 31 October 2028, and can be signed at any time during this period, at the latest by 3 September 2028. Contracts may be terminated with one month's notice to month-end. Companies qualify by submitting a signed declaration of reliability plus contract documents.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 6 days ago
More from this buyer
Full buyer profile103 open tenders right now
- Healthcare services - Video consultation service 2 days left
- Healthcare services - Video medical consultation 9 days left
- Call centre - Contract for call centre services for insured person communication on healthcare contracts 19 days left
This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - Germany
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| Siemens Healthineers AG | 42 | €17.4M | Sep 2026 |
| Philips GmbH | 20 | €5.3M | Sep 2026 |
| GlaxoSmithKline GmbH & Co. KG | 15 | n/a | Sep 2026 |
| ASTRAZENECA GMBH | 12 | n/a | Jul 2026 |
| Brainlab Sales GmbH | 10 | €4.0M | Sep 2026 |
Based on 1018 awards with a linked company profile over the last 2 years.
Similar tenders
2
days left
€2,750,000
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,066,160
- Buyer track record on Aperlena
- 168 notices tracked · 58 awarded
- €0 in awarded contracts
Never miss a tender like this
76 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.
Set up my alert